Literature DB >> 35078349

Community Engagement: Lessons Learned From the AAASPS and SDBA.

Philip B Gorelick1.   

Abstract

Community engagement is a means to help overcome challenges to the delivery of health care and preventative services. On the occasion of the 2021 International Stroke Conference Edgar J. Kenton III Lecture, I review community engagement strategies utilized in the AAASPS trial (African-American Antiplatelet Stroke Prevention Study) and SDBA (Studies of Dementia in the Black Aged) observational studies that I directed. The main community engagement strategies included use of home visits (bringing the study to the community), engagement of churches, community advisors, community physicians, other healthcare providers, major Black community organizations, and utilization of diversity training. Community engagement strategies were a major component of AAASPS and SDBA that helped to ensure successful recruitment and retention of an underrepresented community in clinical trial and observational studies. Lessons learned from these studies largely carried out in the 1980s and 1990s helped to dispel myths that Blacks could not be recruited into large-scale clinical trials, emphasized the importance of studying underrepresented groups with adequate statistical power to test primary study hypotheses, and provided foundational recruitment and retention methods for future consideration.

Entities:  

Keywords:  Alzheimer disease; American Heart Association; National Institutes of Health; aged; dementia

Mesh:

Year:  2022        PMID: 35078349      PMCID: PMC9015676          DOI: 10.1161/STROKEAHA.121.034554

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   10.170


  47 in total

1.  Researchers say changes needed in recruitment policies for NIH trials.

Authors:  Brian Vastag
Journal:  JAMA       Date:  2003-02-05       Impact factor: 56.272

Review 2.  Community-based participatory research: a review of the literature with strategies for community engagement.

Authors:  Madeleine U Shalowitz; Anthony Isacco; Nora Barquin; Elizabeth Clark-Kauffman; Patti Delger; Devon Nelson; Anthony Quinn; Kimberly A Wagenaar
Journal:  J Dev Behav Pediatr       Date:  2009-08       Impact factor: 2.225

Review 3.  Why African Americans may not be participating in clinical trials.

Authors:  Y Harris; P B Gorelick; P Samuels; I Bempong
Journal:  J Natl Med Assoc       Date:  1996-10       Impact factor: 1.798

4.  Effect of sex on outcome after recurrent stroke in African Americans: results from the African American Antiplatelet Stroke Prevention Study.

Authors:  Fernando D Testai; John F Cursio; Philip B Gorelick
Journal:  J Stroke Cerebrovasc Dis       Date:  2010-05-04       Impact factor: 2.136

5.  Stroke risk factor profiles in African American women: an interim report from the African-American Antiplatelet Stroke Prevention Study.

Authors:  Bradford B Worrall; Karen C Johnston; Gail Kongable; Elena Hung; DeJuran Richardson; Philip B Gorelick
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

6.  CT and MRI findings among African-Americans with Alzheimer's disease, vascular dementia, and stroke without dementia.

Authors:  D Charletta; P B Gorelick; T J Dollear; S Freels; Y Harris
Journal:  Neurology       Date:  1995-08       Impact factor: 9.910

7.  Vascular and Alzheimer-type pathology in an autopsy study of African-Americans.

Authors:  P Pytel; E J Cochran; G Bonner; D L Nyenhuis; C Thomas; P B Gorelick
Journal:  Neurology       Date:  2006-02-14       Impact factor: 9.910

8.  Interventions Targeting Racial/Ethnic Disparities in Stroke Prevention and Treatment.

Authors:  Deborah A Levine; Pamela W Duncan; Mai N Nguyen-Huynh; Olugbenga G Ogedegbe
Journal:  Stroke       Date:  2020-10-26       Impact factor: 7.914

9.  HEADS-UP: Understanding and Problem-Solving: Seeking Hands-Down Solutions to Major Inequities in Stroke.

Authors:  Bruce Ovbiagele
Journal:  Stroke       Date:  2020-10-26       Impact factor: 7.914

10.  COVID-19 and Health Equity-A New Kind of "Herd Immunity".

Authors:  David R Williams; Lisa A Cooper
Journal:  JAMA       Date:  2020-06-23       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.